Obesity-related asthma in children and adolescents

J Reyes-Angel, P Kaviany, D Rastogi… - The Lancet Child & …, 2022 - thelancet.com
There is substantial epidemiological and experimental evidence of an obesity-related
asthma phenotype. Compared to children of healthy weight, children with obesity are at …

Practical guidance for the evaluation and management of drug hypersensitivity: specific drugs

AD Broyles, A Banerji, S Barmettler, CM Biggs… - The Journal of Allergy …, 2020 - Elsevier
Allergists and clinical immunologists around the world are increasingly faced with the task of
addressing drug allergy and hypersensitivity due to the increase in drug reactions …

Mechanisms and therapeutic strategies for non‐T2 asthma

E Sze, A Bhalla, P Nair - Allergy, 2020 - Wiley Online Library
Non‐T2 asthma is traditionally defined as asthma without features of T2 asthma. The
definition is arbitrary and is generally based on the presence of neutrophils in sputum, or the …

Simvastatin reduces NETosis to attenuate severe asthma by inhibiting PAD4 expression

YR Chen, XD Xiang, F Sun, BW Xiao… - Oxidative Medicine …, 2023 - Wiley Online Library
Objective. Patients with severe asthma respond poorly to corticosteroids, and their care
accounts for more than 60% of the total costs attributed to asthma. Neutrophils form …

Targeting mast cells in allergic disease: current therapies and drug repurposing

JR Burchett, JM Dailey, SA Kee, DT Pryor, A Kotha… - Cells, 2022 - mdpi.com
The incidence of allergic disease has grown tremendously in the past three generations.
While current treatments are effective for some, there is considerable unmet need. Mast cells …

Association between statin medication and asthma/asthma exacerbation in a national health screening cohort

JH Kim, JH Wee, HG Choi, JY Park, YI Hwang… - The Journal of Allergy …, 2021 - Elsevier
Background Statins, which are a type of 3-hydroxy-3-methylglutaryl-CoA inhibitor, have
multiple therapeutic effects, including anti-inflammatory and immunomodulatory properties …

Rosuvastatin attenuates airway inflammation and remodeling in a chronic allergic asthma model through modulation of the AMPKα signaling pathway

L Zhang, FY Huang, SZ Dai, L Wang, X Zhou… - Plos one, 2024 - journals.plos.org
The efficacy of rosuvastatin in reducing allergic inflammation has been established.
However, its potential to reduce airway remodeling has yet to be explored. This study aimed …

Inhibiting Isoprenylation Suppresses FcεRI-Mediated Mast Cell Function and Allergic Inflammation

JM Dailey, SA Kee, A Tharakan, A Kazi… - The Journal of …, 2023 - journals.aai.org
IgE-mediated mast cell activation is a driving force in allergic disease in need of novel
interventions. Statins, long used to lower serum cholesterol, have been shown in multiple …

Sterols and immune mechanisms in asthma

RD Britt Jr, N Porter, MH Grayson, KM Gowdy… - Journal of Allergy and …, 2023 - Elsevier
The field of sterol and oxysterol biology in lung disease has recently gained attention,
revealing a unique need for sterol uptake and metabolism in the lung. The presence of …

Sterols in asthma

M Guerau-de-Arellano, RD Britt - Trends in immunology, 2022 - cell.com
While sterols regulate immune processes key to the pathogenesis of asthma, inhibition of
sterols with statin drugs has shown conflicting results in human asthma. Here, a novel …